Isidore Tepler

1.2k total citations · 1 hit paper
8 papers, 947 citations indexed

About

Isidore Tepler is a scholar working on Oncology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Isidore Tepler has authored 8 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Hematology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Isidore Tepler's work include Neutropenia and Cancer Infections (2 papers), Hematopoietic Stem Cell Transplantation (2 papers) and Cancer Cells and Metastasis (2 papers). Isidore Tepler is often cited by papers focused on Neutropenia and Cancer Infections (2 papers), Hematopoietic Stem Cell Transplantation (2 papers) and Cancer Cells and Metastasis (2 papers). Isidore Tepler collaborates with scholars based in United States. Isidore Tepler's co-authors include Philip Leder, William J. Muller, Eric Sinn, Paul K. Pattengale, Gerald Rosen, Bernice Kuca, John W. Smith, Laurence Elias, John W. Loewy and James A. Kaye and has published in prestigious journals such as Cell, Cancer and CHEST Journal.

In The Last Decade

Isidore Tepler

8 papers receiving 914 citations

Hit Papers

Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in tra... 1987 2026 2000 2013 1987 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isidore Tepler United States 7 439 421 235 182 168 8 947
JN Ihle United States 11 315 0.7× 334 0.8× 262 1.1× 216 1.2× 183 1.1× 16 753
Kanji Hojo Japan 11 560 1.3× 242 0.6× 73 0.3× 141 0.8× 91 0.5× 21 974
Hong-Ji Xu United States 15 569 1.3× 401 1.0× 81 0.3× 52 0.3× 89 0.5× 19 966
Alessandra Gentile Italy 16 618 1.4× 316 0.8× 168 0.7× 52 0.3× 88 0.5× 28 1.0k
SA Cannistra United States 12 298 0.7× 286 0.7× 89 0.4× 451 2.5× 487 2.9× 20 1.1k
A Rosolen Italy 19 366 0.8× 263 0.6× 87 0.4× 73 0.4× 252 1.5× 45 956
Ari Ristimäki Finland 9 470 1.1× 328 0.8× 116 0.5× 48 0.3× 57 0.3× 13 780
RN Buick Canada 11 381 0.9× 220 0.5× 58 0.2× 417 2.3× 102 0.6× 19 857
Siân Rizzo United Kingdom 15 601 1.4× 301 0.7× 110 0.5× 179 1.0× 138 0.8× 25 1.1k
T Hoang Canada 12 342 0.8× 175 0.4× 70 0.3× 389 2.1× 336 2.0× 19 849

Countries citing papers authored by Isidore Tepler

Since Specialization
Citations

This map shows the geographic impact of Isidore Tepler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isidore Tepler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isidore Tepler more than expected).

Fields of papers citing papers by Isidore Tepler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isidore Tepler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isidore Tepler. The network helps show where Isidore Tepler may publish in the future.

Co-authorship network of co-authors of Isidore Tepler

This figure shows the co-authorship network connecting the top 25 collaborators of Isidore Tepler. A scholar is included among the top collaborators of Isidore Tepler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isidore Tepler. Isidore Tepler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Amato, Joseph J., et al.. (1998). Psychological support to an autologous bone marrow transplant unit in a community hospital: a pilot experience. Psycho-Oncology. 7(2). 121–125. 6 indexed citations
2.
Tepler, Isidore, Laurence Elias, John W. Smith, et al.. (1996). A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy.. PubMed. 87(9). 3607–14. 219 indexed citations
3.
Tepler, Isidore, Gary N. Schwartz, Karen Parker, et al.. (1994). Phase I trial of an interleukin-2 fusion toxin (DAB486IL-2) in hematologic malignancies: Complete response in a patient with Hodgkin's disease refractory to chemotherapy. Cancer. 73(4). 1276–1285. 39 indexed citations
4.
Ayash, Lois, Anthony Elias, M Hunt, et al.. (1994). Recombinant human erythropoietin for the treatment of the anaemia associated with autologous bone marrow transplantation. British Journal of Haematology. 87(1). 153–161. 22 indexed citations
5.
Ayash, Lois, Anthony Elias, Catherine Wheeler, et al.. (1993). High-Dose Chemotherapy with Autologous Stem Cell Support for Breast Cancer: A Review of the Dana-Farber Cancer Institute/Beth Israel Hospital Experience. Journal of Hematotherapy. 2(4). 507–511. 3 indexed citations
6.
Elias, Anthony, Lois Ayash, Arthur T. Skarin, et al.. (1993). High-Dose Combined Alkylating Agent Therapy With Autologous Stem Cell Support and Chest Radiotherapy for Limited Small-Cell Lung Cancer. CHEST Journal. 103(4). 433S–435S. 8 indexed citations
7.
Elias, Anthony, Rosemary Mazanet, C Wheeler, et al.. (1991). GM-CSF potentiated peripheral blood progenitor cell (PBPC) collection with or without bone marrow as hematologic support of high-dose chemotherapy: Two protocols. Breast Cancer Research and Treatment. 20(S1). S25–S29. 16 indexed citations
8.
Sinn, Eric, et al.. (1987). Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo. Cell. 49(4). 465–475. 634 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026